Royal Bank of Canada
MAIA icon

Royal Bank of Canada’s MAIA Biotechnology MAIA Stock Holding History

Royal Bank of Canada’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Buy
+268
New +$494 ﹤0.01% 7447
2025
Q1 		– Sell
-3,000
Closed -$6K – 7065
2024
Q4 		$6K Buy
+3,000
New +$7.19K ﹤0.01% 6498
2024
Q3 		– Sell
-86
Closed – – 7182
2024
Q2 		$0 Buy
86
+58
+207% +$183 ﹤0.01% 7339
2024
Q1 		$0 Sell
28
-120
-81% -$180 ﹤0.01% 7343
2023
Q4 		$0 Buy
148
+121
+448% +$195 ﹤0.01% 7384
2023
Q3 		$0 Hold
27
– – ﹤0.01% 7357
2023
Q2 		$0 Buy
+27
New +$72 ﹤0.01% 7480
2022
Q4 		– Sell
-22
Closed – – 7512
2022
Q3 		$0 Buy
+22
New +$93 ﹤0.01% 7671

Other funds holding MAIA

SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada's MAIA Position: Q1 2026 in Review

Royal Bank of Canada opened a new position in MAIA Biotechnology (MAIA) in Q1 2026: 268 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #7447 among its holdings. This is a return to the name: Royal Bank of Canada previously reported a position in MAIA as recently as Q4 2024.

Royal Bank of Canada first reported a position in MAIA in Q3 2022 and has held it in 8 quarters since. The position peaked at $6K in Q4 2024. 33 funds tracked by Wall St. Rank hold MAIA as of Q1 2026.

  • Royal Bank of Canada held 268 shares of MAIA Biotechnology worth $0 as of Q1 2026.
  • MAIA Biotechnology was a new Royal Bank of Canada position in Q1 2026.
  • MAIA Biotechnology made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7447 holding.
  • Royal Bank of Canada first reported a position in MAIA Biotechnology in Q3 2022 and has held it in 8 quarters since.
  • Royal Bank of Canada's MAIA Biotechnology position peaked at $6K in Q4 2024.
  • 33 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.